Newsletter Tool

To view this email as a web page, click here

Today's Rundown

Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Rural health systems among top recipients of PPP loans
Report: Telehealth claims lines up 8,336% in April due to COVID-19
French biotech Osivax nabs funding boost for universal flu, coronavirus vaccine work
Intermountain, Stanford Children's CEOs say hospitals need to get comfortable being a 'frenemy'
AstraZeneca, Lilly, Sanofi and others raise prices to start July: report
Healthcare roundup: Epidemiologists call for 'Universal Pandemic Precautions' for patients and healthcare workers
Biopharma roundup: CEPI expands Clover vaccine deal with $66M upfront; Cipla undercuts rivals on remdesivir cost
With COVID-19 vaccines coming, SiO2 injects $163M into vial production plant
Groups urge Congress to take action on patient identifier as COVID-19 raises the stakes

Featured Story

Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint

By Arlene Weintraub

As Amgen prepares for clinical trials of its psoriasis drug Otezla in COVID-19, it might also investigate the potential for TNF inhibitors like its blockbuster anti-inflammatory Enbrel to fight the virus, CEO Robert Bradway said. Recent reports of favorable COVID outcomes in patients taking anti-TNF drugs may be fueling the interest.

Rural health systems among top recipients of PPP loans

By Tina Reed

Among the recipients in healthcare granted the most loan funding through the Paycheck Protection Program: rural health systems.

Report: Telehealth claims lines up 8,336% in April due to COVID-19

By Paige Minemyer

Telehealth claims lines have seen massive spikes due to the COVID-19 pandemic and a new report shows just how big those increases are.

French biotech Osivax nabs funding boost for universal flu, coronavirus vaccine work

By Ben Adams

Little Lyon biotech Osivax has grabbed €30 million ($33.8 million) for its universal coronavirus and influenza inoculations.

Intermountain, Stanford Children's CEOs say hospitals need to get comfortable being a 'frenemy'

By Tina Reed

Here's the big lesson health systems need to take away from the COVID-19 pandemic, according to Intermountain CEO Marc Harrison, M.D., and Stanford Children's Health CEO Paul King.

AstraZeneca, Lilly, Sanofi and others raise prices to start July: report

By Eric Sagonowsky

A pandemic hasn’t stopped some drugmakers from pushing through their traditional mid-year price hikes. But though pharmas big and small have raised prices so far this month, the current round of increases is far smaller than January's.

Healthcare roundup: Epidemiologists call for 'Universal Pandemic Precautions' for patients and healthcare workers

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

Biopharma roundup: CEPI expands Clover vaccine deal with $66M upfront; Cipla undercuts rivals on remdesivir cost

By Eric Sagonowsky, Angus Liu, Kyle Blankenship, Conor Hale, Fraiser Kansteiner

CEPI expanded a deal with Clover Biopharmaceuticals and provided $66M upfront to rush the company's vaccine into preclinical tests. Amgen could pivot its TNF inhibitor Enbrel to attack COVID-19. Cipla undercut rivals' prices as it pushed its generic remdesivir to market Wednesday. Plus, the NIAID launched a new clinical trials network.

With COVID-19 vaccines coming, SiO2 injects $163M into vial production plant

By Fraiser Kansteiner

Hundreds of millions of COVID-19 vaccine doses require hundreds of millions of vials, and the U.S. government handed $143 million to materials manufacturer SiO2 to make sure that supply keeps coming. Now, the company is shelling out $163 million to upgrade its Auburn, Alabama, glass vial site and scale up production.

Groups urge Congress to take action on patient identifier as COVID-19 raises the stakes

By Heather Landi

Patient identity and matching problems are not new to healthcare but the current pandemic has exposed long-standing deficiencies in the underlying technology infrastructure, healthcare leaders say.

COVID-19 Tracker